[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@Merck Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::35961145.png) @Merck Merck

Merck posts on X about longterm, acquisition the most. They currently have XXXXXXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.

### Engagements: XXX [#](/creator/twitter::35961145/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::35961145/c:line/m:interactions.svg)

- X Week XXXXX -XXXX%
- X Month XXXXXX +15%
- X Months XXXXXXX +85%
- X Year XXXXXXX +108%

### Mentions: XX [#](/creator/twitter::35961145/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::35961145/c:line/m:posts_active.svg)

- X Week XX +11%
- X Month XX +60%
- X Months XX -XX%
- X Year XXX +390%

### Followers: XXXXXXX [#](/creator/twitter::35961145/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::35961145/c:line/m:followers.svg)

- X Week XXXXXXX no change
- X Month XXXXXXX +0.03%
- X Months XXXXXXX -XXXX%
- X Year XXXXXXX -XXXX%

### CreatorRank: XXXXXXXXX [#](/creator/twitter::35961145/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::35961145/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::35961145/influence)
---

**Social category influence**
[stocks](/list/stocks)  XXXXX% [finance](/list/finance)  XXX%

**Social topic influence**
[longterm](/topic/longterm) 2.7%, [acquisition](/topic/acquisition) XXX%

**Top accounts mentioned or mentioned by**
[@spiking](/creator/undefined) [@nhcoa](/creator/undefined) [@bidonkules](/creator/undefined) [@wethenorth47](/creator/undefined) [@jiyangweitian](/creator/undefined) [@jacks24450](/creator/undefined) [@pigeonsguy](/creator/undefined) [@nmx_research](/creator/undefined) [@p14701331](/creator/undefined) [@sergioaterry](/creator/undefined) [@manondanet](/creator/undefined) [@saner13104](/creator/undefined) [@yaireinhorn](/creator/undefined) [@thelieisfalling](/creator/undefined) [@grok](/creator/undefined) [@hinj_org](/creator/undefined) [@apoptpsis1777](/creator/undefined) [@aquariusofage](/creator/undefined) [@ethan_taylor008](/creator/undefined) [@merckcom](/creator/undefined)
### Top Social Posts [#](/creator/twitter::35961145/posts)
---
Top posts by engagements in the last XX hours

"Today we announced an agreement to acquire EyeBio a clinical-stage ophthalmology-focused biotech company expanding our companys presence in #ophthalmology. Read our news here:"  
[X Link](https://x.com/Merck/status/1795769140852007201) [@Merck](/creator/x/Merck) 2024-05-29T10:48Z 217.5K followers, 4742 engagements


"Today we announced the initiation of three Phase 2b trials in #immunology as part of our commitment to advancing research for certain immune-mediated inflammatory diseases. Learn more here:"  
[X Link](https://x.com/Merck/status/1975151919292391506) [@Merck](/creator/x/Merck) 2025-10-06T10:51Z 217.5K followers, 2085 engagements


"Learn about the latest results from a Phase X study of our #immunotherapy in platinum-resistant recurrent #ovariancancer:"  
[X Link](https://x.com/Merck/status/1978775024652718434) [@Merck](/creator/x/Merck) 2025-10-16T10:48Z 217.5K followers, 1985 engagements


"In collaboration with @EisaiUS we presented five-year follow-up data for the treatment of patients with advanced endometrial cancer. Learn more about the ESMO presentation of our long-term findings:"  
[X Link](https://x.com/Merck/status/1979489500926456152) [@Merck](/creator/x/Merck) 2025-10-18T10:07Z 217.5K followers, 1486 engagements


"Today in collaboration with @pfizer and @AstellasUS we announced results from the KEYNOTE-905 Phase X study in certain patients with muscle-invasive bladder cancer during a Presidential Symposium at ESMO. Learn more here:"  
[X Link](https://x.com/Merck/status/1979556772202336361) [@Merck](/creator/x/Merck) 2025-10-18T14:34Z 217.5K followers, 1169 engagements


"We are pleased to announce that weve completed our acquisition of Verona Pharma bringing talented new colleagues into our company and strengthening our cardiopulmonary footprint. Learn more:"  
[X Link](https://x.com/Merck/status/1975528306884944131) [@Merck](/creator/x/Merck) 2025-10-07T11:47Z 217.5K followers, 2144 engagements


"Were sharing new research across more than XX types of #cancer at this years ESMO Congress. Learn more about the continued impact of our work across advanced cancers and earlier stages of disease:"  
[X Link](https://x.com/Merck/status/1976238509964120219) [@Merck](/creator/x/Merck) 2025-10-09T10:49Z 217.5K followers, 2461 engagements


"We are committed to advancing #HIV research. Learn more about our latest research:"  
[X Link](https://x.com/Merck/status/1976242005652172812) [@Merck](/creator/x/Merck) 2025-10-09T11:03Z 217.5K followers, 3235 engagements


"Today we announced the latest results from our Phase X trial of an investigational treatment for #HIV. Learn how we are continuing to advance our research:"  
[X Link](https://x.com/Merck/status/1978412672145109258) [@Merck](/creator/x/Merck) 2025-10-15T10:48Z 217.5K followers, 1960 engagements


"Were pleased to share new Phase X data for our immunotherapy in platinum-resistant recurrent #OvarianCancer which will be presented in a Presidential Symposium session at ESMO 2025. Learn more:"  
[X Link](https://x.com/Merck/status/1979558281573273628) [@Merck](/creator/x/Merck) 2025-10-18T14:40Z 217.5K followers, 1486 engagements